Sanara MedTech

Sanara MedTech is a company listed under the stock ticker SMTI (US).

View the org chart displaying its 25 main executives

Most searched biographies at Sanara MedTech

• Zachary Fleming, Chief Executive Officer
• Roszell Mack, Director
• Sara Ortwein, Director

Popular executive movements at Sanara MedTech

• Jake Waldrop has joined the company as Chief Operating Officer  (posted on April 7 2024).
• Tyler Palmer has joined the company as Chief Corporate Development and Strategy Officer  (posted on April 7 2024).

Create your alert
to follow the executive moves at Sanara MedTech.

Sanara MedTech has 1,816 competitors including Siemens Healthineers (Germany), IQVIA (United States (USA)) and Saint Francis Health System (United States (USA)).

Popular M&A news in Healthcare

• Xaira Therapeutics becomes a unicorn with its fundraising of $1,000 Million. (posted on April 25 2024).
• Two Chairs has just announced a $72 Million fundraising (posted on April 18 2024).
• Grow Therapy has just announced a $88 Million fundraising (posted on April 12 2024).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Ralph De La Torre - Chairman and Chief Executive Officer at Steward Health Care
• Sima Sistani - Chief Executive Officer and Director at WW International

Learn more about the Healthcare industry >

Press releases by Sanara MedTech

• Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
• Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results - Sanara MedTech
• Press Releases | Sanara MedTech Inc.
• Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
• Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
• Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides  - Sanara MedTech
• Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing 
• Sanara MedTech Inc. Announces Third Quarter 2023 Results 
• Press Releases | Sanara MedTech Inc.
• Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
• View more press releases Close

Social media about Sanara MedTech

• Sanara MedTech on Wikipedia, Google News & Yahoo Finance
• Sanara MedTech on LinkedIn, Twitter & YouTube

Contact by email its executives including Roszell Mack

Call Sanara MedTech at +1 817...

View the org chart

Register to receive your alert

Report an error